Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00 at Needham & Company LLC

Omada Health (NASDAQ:OMDA) had its price target lifted by Needham & Company LLC from $26.00 to $28.00 in a research note released on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other research firms also recently issued reports on OMDA. Evercore ISI set a $27.00 price objective on shares of Omada Health in a report on Wednesday, October 8th. Canaccord Genuity Group boosted their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Barclays raised their price target on Omada Health from $24.00 to $28.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Finally, Robert W. Baird began coverage on Omada Health in a research report on Friday, September 5th. They set a “neutral” rating and a $24.00 price objective for the company. Seven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $26.25.

Omada Health Stock Performance

Shares of OMDA stock traded down $1.56 during trading on Friday, reaching $20.31. The company had a trading volume of 1,749,606 shares, compared to its average volume of 439,663. The stock has a 50 day moving average price of $23.70. Omada Health has a one year low of $14.14 and a one year high of $28.40.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The business had revenue of $61.37 million during the quarter, compared to the consensus estimate of $55.17 million.

Institutional Investors Weigh In On Omada Health

Institutional investors have recently added to or reduced their stakes in the company. Cigna Investments Inc. New acquired a new position in Omada Health in the 3rd quarter valued at approximately $76,161,000. Perceptive Advisors LLC acquired a new stake in shares of Omada Health during the 2nd quarter worth approximately $44,402,000. Loomis Sayles & Co. L P bought a new stake in shares of Omada Health during the second quarter valued at approximately $19,948,000. Sanofi acquired a new position in shares of Omada Health in the second quarter valued at $9,606,000. Finally, Federated Hermes Inc. bought a new position in Omada Health in the second quarter worth $9,150,000.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.